CIK 0000064803 · Large accelerated filer
CVS HEALTH Corp
Sign in to watch- Ticker
- CVS
- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 050494040
- Phone
- 4017651500
- Business address
- ONE CVS DR., WOONSOCKET, RI, 02895
- Former names
- CVS CAREMARK CORP, CVS/CAREMARK CORP, CVS CORP, MELVILLE CORP
- Open-market buys, last 90 days
- $2,001,315
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,001,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | Havanec Laurie P. EVP and Chief People Officer | Grant or award · Stock Option | +39,184 | $79.56 | $3.1M | 39,184 |
| 2024-04-01 | Joyner J. David EVP&President-PharmacyServices | Grant or award | +28,280 | 44,241 | ||
| 2024-04-01 | Kane Brian A EVP/President, Aetna | Grant or award | +12,569 | 12,569 | ||
| 2024-04-01 | Kane Brian A EVP/President, Aetna | Grant or award · Stock Option | +52,246 | $79.56 | $4.2M | 52,246 |
| 2024-04-01 | Khichi Samrat S. EVP, CPO and General Counsel | Grant or award | +12,569 | 44,490 | ||
| 2024-04-01 | Khichi Samrat S. EVP, CPO and General Counsel | Grant or award · Stock Option | +52,246 | $79.56 | $4.2M | 52,246 |
| 2024-04-01 | COWHEY THOMAS F. EVP and CFO | Shares withheld for taxes | −1,719 | $79.56 | $137K | 35,642 |
| 2024-04-01 | COWHEY THOMAS F. EVP and CFO | Grant or award | +15,082 | 47,995 | ||
| 2024-04-01 | COWHEY THOMAS F. EVP and CFO | Grant or award · Stock Option | +62,695 | $79.56 | $5.0M | 62,695 |
| 2024-04-01 | Shah Prem S EVP and Pres-Pharm, Consumer W | Shares withheld for taxes | −2,653 | $79.56 | $211K | 47,273.46 |
| 2024-04-01 | Shah Prem S EVP and Pres-Pharm, Consumer W | Shares withheld for taxes | −5,239 | $79.56 | $417K | 42,034.46 |
| 2024-04-01 | Shah Prem S EVP and Pres-Pharm, Consumer W | Grant or award | +15,082 | 37,057 | ||
| 2024-04-01 | Shah Prem S EVP and Pres-Pharm, Consumer W | Grant or award · Stock Option | +62,695 | $79.56 | $5.0M | 62,695 |
| 2024-04-01 | Mandadi Tilak EVP, Chief Technology Officer | Grant or award | +16,339 | 82,904 | ||
| 2024-04-01 | Mandadi Tilak EVP, Chief Technology Officer | Grant or award · Stock Option | +67,920 | $79.56 | $5.4M | 67,920 |
| 2024-04-01 | Lynch Karen S President and CEO | Grant or award | +45,248 | $79.56 | $3.6M | 45,248 |
| 2024-04-01 | Lynch Karen S President and CEO | Shares withheld for taxes | −61,953 | $79.56 | $4.9M | 74,687 |
| 2024-04-01 | Lynch Karen S President and CEO | Grant or award · Stock Option | +188,087 | $79.56 | $15.0M | 188,087 |
| 2024-02-28 | Joyner J. David EVP&President-PharmacyServices | Shares withheld for taxes | −1,970 | $75.19 | $148K | 40,681 |
| 2024-02-28 | COWHEY THOMAS F. SVP, Interim CFO | Shares withheld for taxes | −5,641 | $75.19 | $424K | 28,631 |
Page 10 of 15 · 283 trades